Clinical Study

Self-Monitoring of Blood Glucose to Assess Dawn Phenomenon in Chinese People with Type 2 Diabetes Mellitus

Table 1

Characteristics and glucose levels of total population and groups treated with insulin sensitizers, insulin secretagogues, and insulin sensitizers plus insulin secretagogues.

VariablesTotalInsulin sensitizersInsulin secretagoguesSensitizers + secretagoguesa value

Number (M/F)306 (191/115)80 (56/24)111 (68/43)115 (67/48)0.238
Age (years)66.2 ± 10.965.8 ± 11.164.1 ± 12.068.42 ± 9.20.011
BMI (kg/m2)25.3 ± 2.226.7 ± 2.524.6 ± 2.624.4 ± 2.10.054
Duration (years)10.9 ± 6.78.5 ± 4.110.0 ± 7.513.4 ± 6.60.000
Mean daily energy intake (kcal)1498.5 ± 202.11528.2 ± 198.61505.2 ± 196.21472.0 ± 208.40.151
Mean daily carbohydrate intake (g)187.3 ± 25.3191.0 ± 24.8188.1 ± 24.5184.0 ± 26.10.151
Fasting insulin (μU/mL)9.9 ± 6.212.8 ± 7.49.5 ± 6.48.2 ± 5.60.002
HOMA-IR3.3 ± 3.14.0 ± 3.93.1 ± 2.22.8 ± 2.20.033
HbA1c (%)7.1 ± 0.96.7 ± 0.97.1 ± 0.97.3 ± 0.80.000
Triglyceride (mmol/L)1.6 ± 1.01.5 ± 0.71.6 ± 1.21.5 ± 1.00.617
Total cholesterol (mmol/L)4.3 ± 1.14.4 ± 1.24.4 ± 1.14.2 ± 1.00.209
PreBF (mg/dL)136.3 ± 26.3132.1 ± 26.7136.6 ± 24.0138.9 ± 28.10.197
PostBF (mg/dL)166.6 ± 41.5159.0 ± 46.2166.0 ± 38.7172.5 ± 40.00.082
PreL (mg/dL)133.7 ± 37.8128.8 ± 38.9133.9 ± 35.0137.1 ± 39.40.322
PreD (mg/dL)146.1 ± 39.7132.6 ± 38.5144.9 ± 36.0157.1 ± 41.30.000
Bedtime (mg/dL)151.7 ± 38.9143.7 ± 40.1151.7 ± 37.8157.4 ± 38.60.056
Nadir (mg/dL)114.5 ± 25.8107.7 ± 22.7116.6 ± 24.6117.2 ± 28.10.022
ΔDawn (mg/dL)22.4 ± 20.824.7 ± 22.920.2 ± 19.822.9 ± 22.10.364
Dawn phenomenon (%)116 (37.9)34 (42.5)35 (31.5)47 (40.9)0.216

Data are means ± SD or number (percentage).
a value among groups.
BMI: body mass index; HOMA-IR: homeostatic model assessment of insulin resistance; preBF: prebreakfast; postBF: postbreakfast; preL: prelunch; preD: predinner; ΔDawn, difference between prebreakfast and nocturnal nadir glucose values; dawn phenomenon, ΔDawn  mg/dL.